Antiproliferative Properties of Type I and Type II Interferon

• Main Authors: Joseph Bekisz (Author), Samuel Baron (Author), Corey Balinsky (Author), Angel Morrow (Author), Kathryn C. Zoon (Author)
• Format: Book
• Published: MDPI AG, 2010-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The clinical possibilities of interferon (IFN) became apparent with early studies demonstrating that it was capable of inhibiting tumor cells in culture and in vivo using animal models. IFN gained the distinction of being the first recombinant cytokine to be licensed in the USA for the treatment of...